NCT03785678: A reported trial by Genentech, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03785678 |
|---|---|
| Title | A Phase III, Prospective, Double-blind, Randomized, Placebo-controlled Trial of Thrombolysis in Imaging-eligible, Late-window Patients to Assess the Efficacy and Safety of Tenecteplase (TIMELESS) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 2, 2019 |
| Completion date | Feb. 28, 2023 |
| Required reporting date | Feb. 28, 2024, midnight |
| Actual reporting date | Feb. 20, 2024 |
| Date last checked at ClinicalTrials.gov | May 30, 2025 |
| Days late | None |